Combination Drug Treatment to Increase Neurogenesis for Neurological Disorders

Technology #11616

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Categories
Researchers
Kiminobu Sugaya, Ph.D.
Patent Protection

Provisional Patent Application Filed

Key Points

  • Combination treatment for promoting neuroregeneration and suppressing inflammation
  • May be used to treat neuronal damage caused by conditions such as stroke, Alzheimer's disease, ALS, MS, Parkinson's disease, traumatic brain injury,

Abstract

The University of Central Florida invention relates to a combination therapy to promote neuroregeneration consisting of 1) MS-818 to increase endogenous neural stem cells and 2) non-steroidal anti-inflammatory drugs to suppress inflammation